Clinicaltrials.gov: Rep. Waxman Asks PhRMA To Describe Compliance Efforts
Executive Summary
The Pharmaceutical Research & Manufacturers of America will describe its efforts to increase submissions to the National Library of Medicine's clinical trial registry in response to a request from Rep. Henry Waxman (D-Calif.
You may also be interested in...
Antidepressant Investigations Continue; GAO Studying FDA Process
The Government Accountability Office is studying how FDA resolves internal disputes about drug safety issues
Antidepressant Investigations Continue; GAO Studying FDA Process
The Government Accountability Office is studying how FDA resolves internal disputes about drug safety issues
FDA Unlikely To Act Unilaterally To Increase ClinicalTrials.gov Postings
FDA believes it has the authority to independently post clinical study information on ClinicalTrials.gov, but does not plan to create a systematic process for increasing the number of industry-sponsored trials listed on the site